Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP)

CUSIP: 04216R102

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
66,747,845
Total 13F shares
163,127
Share change
+32,044
Total reported value
$531,000
Price per share
$3.27
Number of holders
11
Value change
+$103,852
Number of buys
3
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 04216R102?
CUSIP 04216R102 identifies ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q4 2019

As of 31 Dec 2019, Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 163,127 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, STIFEL FINANCIAL CORP, EDGEWOOD MANAGEMENT LLC, VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., BANK OF MONTREAL /CAN/, MORGAN STANLEY, UBS Group AG, and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.